The HIVdb system for HIV-1 genotypic resistance interpretation

Intervirology

Volumn 55, Issue 2, 2012, Pages 98-101

  Tang, Michele W ^a   Liu, Tommy F ^a   Shafer, Robert W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance mutations; Genotypic resistance; HIV 1; Online resource

Indexed keywords

INTEGRASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; GENE MUTATION; GENE SEQUENCE; GENETIC RESISTANCE; GENOTYPE; HIVDB SYSTEM; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; ONLINE SYSTEM; PRIORITY JOURNAL; QUALITY CONTROL; WEB BROWSER;

ANTI-HIV AGENTS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DATABASES, GENETIC; HIV INFECTIONS; HIV-1; HUMANS; INTERNET; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856426049     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000331998     Document Type: Article

References (14)

1. Rhee SY, Gonzales MJ, Kantor R, Betts BJ, Ravela J, Shafer RW: Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2003;31:298-303.
2. Liu TF, Shafer RW: Web resources for HIV type 1 genotypic-resistance test interpretation. Clin Infect Dis 2006;42:1608-1618.
3. Gifford RJ, Rhee SY, Eriksson N, Liu TF, Kiuchi M, Das AK, et al: Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance. AI-graveS 2008;22:717-725.
4. Betts BJ, Shafer RW: Algorithm specification interface for human immunodeficiency virus type 1 genotypic interpretation. J Clin Microbiol 2003;41:2792-2794.
5. Schapiro JM, Scherer J, Boucher CA, Baxter J-grave, Tilke C, Perno CF, et al: Improving the prediction of virological response to tipranavir: the development and validation of a tipranavirweighted mutation score. Antivir Ther 2010;15:1011-1019.
6. de Meyer S, Vangeneugden T, van Baelen B, de Paepe E, van Marck H, Picchio G, et al: Resistance profile of darunavir: combined 24-week results from the POWER trials. AI-graveS Res Hum Retroviruses 2008;24:379-388.
7. Vingerhoets J, Tambuyzer L, Azijn H, Hoogstoel A, Nijs S, Peeters M, et al: Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled phase III clinical studies. AI-graveS 2010;24:503-514.
8. Rhee SY, Kantor R, Katzenstein DA, Camacho R, Morris L, Sirivichayakul S, et al: HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AI-graveS 2006;20:643-651.
9. (ANRS) ANdRslS: ANRS genotypic resistance guidelines (version 19). http://www.hivfrenchresistance.org/; July 2010.
10. Van Laethem K, De Luca A, Antinori A, Cingolani A, Perna CF, Vandamme AM: A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients. Antivir Ther 2002;7:123-129.
11. Alcantara L, Cassol S, Libin P, Deforche K, Pybus O, Van Ranst M, et al: A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 2009;1-9.
12. de Oliveira T, Deforche K, Cassol S, Salminem M, Paraskevis D, Seebregts C, et al: An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005;21:3797-3800.
13. Rhee SY, Fessel WJ, Liu TF, Marlowe NM, Rowland CM, Rode RA, et al: Predictive value of HIV-1 genotypic resistance test interpretation algorithms. J Infect Dis 2009;200:453-463.
14. Altmann A, Beerenwinkel N, Sing T, Savenkov I, Doumer M, Kaiser R, et al: Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance. Antivir Ther 2007;12:169-178.